Biotech financing: the risk components, ‘going long’ and patents as knowledge currency
The Valley of Death was not a nice place This is the fifth post in a series of six on biotech. The earlier posts can be found here (int...
Suleman Ali -
Sunday, February 01, 2015
Biotech financing: the risk components, ‘going long’ and patents as knowledge currency
Reviewed by Suleman Ali
on
Sunday, February 01, 2015
Rating: